Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11641675 | chr16:90031427 | T/A | 1.23E-8 | 171 | 25.67 | 20.28 | 6.62 | KM Plot |
PCPG | rs11641713 | chr16:90134325 | C/A | 8.72E-9 | 176 | 25.87 | 20.17 | 6.62 | KM Plot |
PCPG | rs11641726 | chr16:89891619 | G/A | 0.000192 | 173 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs11641897 | chr16:89927265 | C/T | 0.000185 | 173 | 25.87 | 22.63 | 36.37 | KM Plot |
PCPG | rs11642010 | chr16:89845111 | T/C | 0 | 175 | 25.87 | 20.13 | 3.17 | KM Plot |
PCPG | rs11642106 | chr16:85226751 | T/G | 1.76E-7 | 171 | 25.92 | 23.43 | 17.43 | KM Plot |
PCPG | rs11642267 | chr16:89957635 | T/C | 0.000167 | 176 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs11642451 | chr16:89958127 | T/C | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
PCPG | rs11642820 | chr16:90142455 | G/C | 8.74E-9 | 176 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs11642823 | chr16:90132786 | C/T | 6.43E-9 | 178 | 6.62 | 20.28 | 25.77 | KM Plot |
PCPG | rs11642999 | chr16:90118119 | C/T | 6.56E-9 | 178 | 25.77 | 20.28 | 6.62 | KM Plot |
PCPG | rs11643086 | chr16:89928498 | G/A | 0.000199 | 172 | 25.87 | 22.63 | 36.37 | KM Plot |
PCPG | rs11643147 | chr16:90038647 | A/G | 1.26E-8 | 171 | 25.77 | 20.2 | 6.62 | KM Plot |
PCPG | rs11643204 | chr16:89897930 | C/T | 0.000207 | 171 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs11643231 | chr16:90148217 | T/G | 8.74E-9 | 176 | 25.87 | 20.2 | 6.62 | KM Plot |